Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case Study

Abstract The therapeutic options for disease modification in relapsing-remitting multiple sclerosis (RRMS) have expanded remarkably in the last 15 years. Although intravenous immunoglobulins (IVIg) have shown some therapeutic effects in multiple sclerosis, reducing global supplies, restriction of tr...

Full description

Bibliographic Details

Published in:	Neurology and Therapy
Main Authors:	Srishti Gupta, Mohnish Suri, Cris S. Constantinescu
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2020-08-01
Subjects:	Ehlers-Danlos syndrome IVIg Muir-Torre syndrome Multiple sclerosis
Online Access:	https://doi.org/10.1007/s40120-020-00209-0